Upadacitinib is a selective Janus kinase (JAK) inhibitor used in the treatment of autoimmune diseases such as rheumatoid arthritis and atopic dermatitis. It modulates the immune response by targeting pathways involved in inflammation. It provides an alternative to biologic therapies.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Upadacitinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Upadacitinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Upadacitinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
